Yale University

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.

TitleAntiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions.
Publication TypeJournal Article
Year of Publication2014
AuthorsCaniglia, Ellen C., Lauren E. Cain, Amy Justice, Janet Tate, Roger Logan, Caroline Sabin, Alan Winston, Ard van Sighem, Jose M. Miro, Daniel Podzamczer, Ashley Olson, José Ramón Arribas, Santiago Moreno, Laurence Meyer, Jorge del Romero, François Dabis, Heiner C. Bucher, Gilles Wandeler, Georgia Vourli, Athanasios Skoutelis, Emilie Lanoy, Jacques Gasnault, Dominique Costagliola, and Miguel A. Hernán
Corporate AuthorsHIV-CAUSAL Collaboration
JournalNeurology
Volume83
Issue2
Pagination134-41
Date Published2014 Jul 8
ISSN1526-632X
KeywordsAdult, AIDS Dementia Complex, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Case Management, CD4 Lymphocyte Count, Central Nervous System, Cohort Studies, Female, Follow-Up Studies, HIV Infections, HIV-1, Humans, Logistic Models, Male, Middle Aged, Prospective Studies, Young Adult
AbstractThe link between CNS penetration of antiretrovirals and AIDS-defining neurologic disorders remains largely unknown.
DOI10.1212/WNL.0000000000000564
Alternate JournalNeurology

External Links